GGrantIndex
← Leaderboards

Joseph Loscalzo

Brigham And Women'S Hospital

$36,255,197
Attributed
$49,328,820
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.6M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$56,199,626 · 15

By mechanism

U54$18,841,298 · 1
U01$13,630,211 · 3
R01$8,668,262 · 4
P50$8,556,250 · 3
R37$4,254,522 · 1
P01$2,238,420 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Environment

Research focus

EnvironmentMolecularInsightResponseGlutathione PeroxidaseCommunitiesNitric OxideCellsEventBostonLaboratoriesGenesPathway InteractionsGenerationsProgramsLeadPhenotypeProteomicsAntioxidantsMeetingsMemberGene ExpressionMetabolismOxygen

Grant awards (76)

Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle Cells$695,923
R01 · FY2025 · HL · contact PI
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia$689,774
R01 · FY2025 · HL · contact PI
Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle Cells$682,004
R01 · FY2024 · HL · contact PI
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia$676,324
R01 · FY2024 · HL · contact PI
Branched-chain Keto-acids and Aerobic Glycolysis in Vascular Smooth Muscle Cells$696,155
R01 · FY2023 · HL · contact PI
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia$690,126
R01 · FY2023 · HL · contact PI
Center for Integrated Approaches to Undiagnosed Diseases$518,031
U01 · FY2023 · NS · contact PI
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia$690,179
R01 · FY2022 · HL · contact PI
Center for Integrated Approached to Undiagnosed Diseases$328,215
U01 · FY2022 · HG · contact PI
Center for Integrated Approached to Undiagnosed Diseases$188,666
U01 · FY2022 · HG · contact PI
Boston Biomedical Innovation Center$1,243,351
U54 · FY2021 · HL · contact PI
L-2-Hydroxyglutarate and Metabolic Remodeling in Hypoxia$690,720
R01 · FY2021 · HL · contact PI
Center for Integrated Approached to Undiagnosed Diseases$550,000
U01 · FY2021 · HG · contact PI
Boston Biomedical Innovation Center$1,760,250
U54 · FY2020 · HL · contact PI
Center for Integrated Approached to Undiagnosed Diseases$550,000
U01 · FY2020 · HG · contact PI
Boston Biomedical Innovation Center$996,736
U54 · FY2019 · HL · contact PI
Center for Integrated Approached to Undiagnosed Diseases$750,000
U01 · FY2019 · HG · contact PI
Boston Biomedical Innovation Center$1,996,061
U54 · FY2018 · HL · contact PI
Center for Integrated Approached to Undiagnosed Diseases$750,000
U01 · FY2018 · HG · contact PI
Center for Integrated Approaches to Undiagnosed Diseases$45,678
U01 · FY2018 · HG · contact PI
Center for Integrated Approaches to Undiagnosed Diseases$2,282,886
U01 · FY2017 · HG · contact PI
Boston Biomedical Innovation Center$1,496,061
U54 · FY2017 · HL · contact PI
Boston Biomedical Innovation Center$808,333
U54 · FY2017 · HL · contact PI
Boston Biomedical Innovation Center$2,839,061
U54 · FY2016 · HL · contact PI
Center for Integrated Approaches to Undiagnosed Diseases$2,288,418
U01 · FY2016 · HG · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$420,383
R37 · FY2016 · HL · contact PI
Center for Integrated Approaches to Undiagnosed Diseases$100,000
U01 · FY2016 · HG · contact PI
Boston Biomedical Innovation Center$2,162,403
U54 · FY2015 · HL · contact PI
Center for Integrated Approaches to Undiagnosed Diseases$1,792,198
U01 · FY2015 · HG · contact PI
Boston Biomedical Innovation Center$1,062,000
U54 · FY2015 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$414,077
R37 · FY2015 · HL · contact PI
Boston Biomedical Innovation Center$2,163,865
U54 · FY2014 · HL · contact PI
Boston Biomedical Innovation Center$1,118,503
U54 · FY2014 · HL · contact PI
Center for Integrated Approaches to Undiagnosed Diseases$798,466
U01 · FY2014 · HG · contact PI
The Phathophenotype Landscape of Complex Disease$647,185
U01 · FY2014 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$411,975
R37 · FY2014 · HL · contact PI
Boston Biomedical Innovation Center$1,194,674
U54 · FY2013 · HL · contact PI
The Phathophenotype Landscape of Complex Disease$641,794
U01 · FY2013 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$400,204
R37 · FY2013 · HL · contact PI
The Phathophenotype Landscape of Complex Disease$687,514
U01 · FY2012 · HL · contact PI
Targeted Delivery of Progenitor Cells to the Lung$512,767
P50 · FY2012 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$420,383
R37 · FY2012 · HL · contact PI
The Phathophenotype Landscape of Complex Disease$711,160
U01 · FY2011 · HL · contact PI
Targeted Delivery of Progenitor Cells to the Lung$512,749
P50 · FY2011 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$437,500
R37 · FY2011 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$437,500
R37 · FY2010 · HL · contact PI
Oxidant Stress and Thiol Redox State in Endothelial Cells$454,351
P01 · FY2009 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$437,500
R37 · FY2009 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$437,500
R37 · FY2008 · HL · contact PI
Oxidant Stress and Thiol Redox State in Endothelial Cells$436,492
P01 · FY2008 · HL · contact PI
Oxidant Stress and Thiol Redox State in Endothelial Cells$460,220
P01 · FY2007 · HL · contact PI
GPx-3 and Peroxide Flux in the Endothelial Cell$437,500
R37 · FY2007 · HL · contact PI
Oxidant Stress and Thiol Redox State in Endothelial Cells$450,062
P01 · FY2006 · HL · contact PI
GPx-3, Vascular Oxidant Stress, and Thrombosis$256,331
R01 · FY2006 · HL · contact PI
NETWORK ANALYSIS OF NITRIC OXIDE PATHWAY IN ENDOTHELIAL CELLS$5,338
P41 · FY2006 · RR · contact PI
Oxidant Stress and Thiol Redox State in Endothelial Cells$437,295
P01 · FY2005 · HL
GPx-3, Vascular Oxidant Stress, and Thrombosis$262,375
R01 · FY2005 · HL
NETWORK ANALYSIS OF NITRIC OXIDE PATHWAY IN ENDOTHELIAL CELLS$5,325
P41 · FY2005 · RR
SCOR IN ISCHEMIC HEART DISEASE IN BLACKS$1,456,398
P50 · FY2004 · HL
Homocyst(e)ine, Oxidative Stress, and Nitric Oxide$326,000
R01 · FY2004 · HL
GPx-3, Vascular Oxidant Stress, and Thrombosis$244,500
R01 · FY2004 · HL
SCOR IN ISCHEMIC HEART DISEASE IN BLACKS$1,370,078
P50 · FY2003 · HL
Homocyst(e)ine, Oxidative Stress, and Nitric Oxide$326,000
R01 · FY2003 · HL
GPx-3, Vascular Oxidant Stress, and Thrombosis$244,500
R01 · FY2003 · HL
SCOR IN ISCHEMIC HEART DISEASE IN BLACKS$1,383,918
P50 · FY2002 · HL
Homocyst(e)ine, Oxidative Stress, and Nitric Oxide$326,000
R01 · FY2002 · HL
GPx-3, Vascular Oxidant Stress, and Thrombosis$244,500
R01 · FY2002 · HL
G6PD, OXIDATIVE STRESS AND NITRIC OXIDE INSUFFICIENCY$219,976
P50 · FY2002 · HL
SCOR IN ISCHEMIC HEART DISEASE IN BLACKS$1,340,557
P50 · FY2001 · HL
Homocyst(e)ine, Oxidative Stress, and Nitric Oxide$326,000
R01 · FY2001 · HL
G6PD, OXIDATIVE STRESS AND NITRIC OXIDE INSUFFICIENCY$219,976
P50 · FY2001 · HL
PLATELET DERIVED REACTIVE OXYGEN SPECIES AND PLAQUE$153,863
R01 · FY2001 · HL
SCOR IN ISCHEMIC HEART DISEASE IN BLACKS$1,319,855
P50 · FY2000 · HL
HOMOCYST(E)INE, OXIDATIVE STRESS, AND NITRIC OXIDE$293,125
R01 · FY2000 · HL
G6PD, OXIDATIVE STRESS AND NITRIC OXIDE INSUFFICIENCY$219,976
P50 · FY2000 · HL
PLATELET DERIVED REACTIVE OXYGEN SPECIES AND PLAQUE$153,863
R01 · FY2000 · HL